Importantly, patients should be aware of key safety concerns with Wegovy, including risks of pancreatitis, gallbladder disease, dehydration leading to acute kidney injury, and potential worsening of diabetic retinopathy in people with type 2 diabetes
Why is a clinical team so essential
Notably, oral semaglutide (Wegovy) became the first oral GLP-1 approved for weight loss and weight loss plus secondary CV risk reduction
Clinical trials show that weight loss continues to build over time, with the most significant results seen between 36 and 72 weeks of consistent treatment
If youre interested in longevity supplements, Nicotinamide Adenine Dinucleotide (NAD+) is also available, with the same simple, streamlined process
Ryan Wood to explore whether Tirzepatide could support your journey toward better movement, energy, and health